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1. Introduction 
The present report describes a new, slightly 
unstable hemoglobin which has been observed in a 
Portuguese woman. This new variant, identified as 
(320 (B2) Val -+ Asp, is a homologue of Hb Olympia 
[l] fi20 (B2) Vale Met a variant which exhibits a 
high oxygen affinity and erythrocytosis. In contrast 
to Hb Olympia, Hb Strasbourg is not associated with 
erythrocytosis. The new variant of hemoglobin can- 
not be separated from HbA by routine electrophoretic 
methods, suggesting that the charge on the aspartic 
acid side-chain is suppressed as a result of its burial 
in a hydrophobic region of the molecule. The forma- 
tion of a salt bridge between the aspartic side chain 
and an ammo group located in the neighbourhood 
also appears likely. 
2. Materials and methods 
Routine hematological examinations were perfor- 
med by standard methods [2] on fresh blood speci- 
mens. Hemolysates were prepared according to 
Drabkin [3]. Tests for heat stability, isopropanol 
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solubility and dissociation resulting from the reaction 
of hemoglobin with PHMB (p-hydroxy-mercuriben- 
zoate) were carried out as previously described [4]. 
Hemolysates were subjected to electrophoresis on 
cellulose-acetate [5] . Isoeletric focusing on horizon- 
tal polyacrylamide gel [6] was performed over the 
pH range 6.0-8.0. Globin electrophoresis was carried 
out in 6.0 M urea [7]. 
Since the new’variant was not separated from 
HbA by routine chromatographic methods, globin 
was prepared from the total hemolysate [8] . The 
abnormal @hain was separated by carboxymethyl- 
cellulose chromatography in 8.0 M urea buffer [9] 
and aminoethylated. Tryptic peptides were isolated 
by analytical and preparative fingerprints on thin- 
layer silica-gel plates (Schleicher and Schiill) accord- 
ing to Braconnier [lo] and their ammo acid composi- 
tion established on a Jeol JLC 5 A H amino acid 
analyser. Sequential analysis of amino acid residues 
was performed by combined Edman degradation and 
dansylation as previously described [ Ill. 
3. Results 
3.1. Hematology and hemoglobin electrophoresis 
The new variant was observed in an 18 year old 
woman who originated from Esposende (northern 
Portugal). Throughout this time, her hematological 
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characteristics including red and white blood cell 
count, platelet count, reticulocyte index, and red cell 
morphology were completely normal. 
Electrophoresis of the propositus sample on 
cellulose-acetate in Tris-EDTA-borate buffer, at 
pH 8.6, revealed a wider band than that of the 
control HbA and resembled that produced by a 
mixture of HbA and Hb Hope (fig.1). The level of 
HbAa was normal; the isopropanol stability test 
produced a small precipitate after 20 min. Reaction 
of hemoglobin with PHMB did not demonstrate the 
presence of a PHMB unstable variant. Globin electro- 
phoresis in 6.0 M urea indicated the presence of fast 
moving (/IJ)-chains which represented about 40% of 
the total p-chains. All these results were in accordance 
with the results obtained with Hb Hope [ 121. In 
fact electrofocusing demonstrated that the hemolysate 
from the patient did not contain Hb Hope but a variant 
exhibiting a slightly more acidic p1 (tig.2). 
3.2. Structural studies 
The fingerprint of the tryptic digest of the amino- 
ethylated P-chain from Hb Strasbourg that the pT3 
was replaced by a new, more polar and more nega- 
tively charged peptide (fig.3). 
The amino acid composition of this new peptide 
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Fig.1. Electrophoresis on cellulose-acetate strips (Tris- 
EDTA-borate buffer, pH 8.6) of hemolysates prepared 
from the following (left to right): (a) Hope trait, (b) normal 
adult, (c) blood from the proband. 
a b c d 
Fig.2. Relative mobilities of two hemoglobin mutants by 
horizontal polyacrylamide gel isoelectric focusing (left to 
right): (a) Hope hemolysate, (b) equal mixture of Hope 
hemolysate and Strasbourg hemolysate, (c) Strasbourg hemo 
lysate, (d) controL 
(table 1) differed from normal in lacking one residue 
of valine and in containing an extra residue of aspartic 
acid. Asparagine is converted to aspartic acid during 
hydrolysis which precedes amino acid analysis; a 
Val + Asn substitution could however be excluded in 
view of the increased negative charge of the abnormal 
P-chains. 
On account of the presence of three residues of 
valine in the normal PT3, it was not possible to 
c --4b-+ # 
Fig. 3. Fingerprint of Tryptic peptides from the AE p-chain 
of Hb Strasbourg. The arrow shows the position of the new 
pT3 peptide. The dotted circle indicates the position 
occupied by pT3 peptide in the control. 
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Table 1 
Amino acid composition of the pT3 peptide 
from Hb Strasbourg 
Amino acid Molar ratios 
Arginine 
Aspartic acid 
Glutamic acid 
Glycine 
Alanine 
Valine 
Leucine 
Found Normal @T3 
0.98 1 
2.98 2 
2.19 2 
3.20 3 
1.02 1 
1.58 3 
0.99 1 
determine which one was replaced by an aspartic 
acid residue. In order to distinguish between these 
three positions, the abnormal peptide was eluted 
from two preparative fingerprints and subjected 
to dansyl-Edman degradation. The results obtained 
gave the following sequence: 
18 19 20 21 
Val-Asn-Asp--Asp-C%- 
--II/ 
Hemoglobin Strasbourg therefore contains the 
amino acid substitution 020 (B2) Val 4 Asp. 
4. Discussion 
The new variant, I-lb Strasbourg p20 (B2) Val + 
Asp, is a homologue of Hb Olympia p20 (B2) 
Val -+ Met [l] , an electrophoretically silent variant 
which was detected as a result of its high oxygen 
affinity and associated erythrocytosis. The structural 
change involves a residue which appears to be located 
at the surface of the polypeptide and which is not 
implicated in the allosteric interactions between sub- 
units. Further studies of Hb Strasbourg will be neces- 
sary to determine the functional implication of the 
substitution. It was of interest to compare such 
results with those obtained for Hb Olympia. Thus no 
erythrocytosis and no hematological abnormalities 
could be detected in the patient with Hb Strasbourg. 
Since the variant is poorly separated from HbA 
upon electrophoresis, it seems likely that the charge 
on the aspartic acid side chain in Hb Strasbourg is 
buried whilst it is in position within the tetramer. 
Another variant of hemoglobin, Hb Hope p136 (H14) 
Gly + Asp, cannot be separated from HbA by 
routine electrophoretic methods [12]. Perutz in 
1968 [ 131 proposed the formation of a new salt 
bridge between Asp 136 and the N-terminal valine in 
the I-lb Hope chain. This hypothesis was recently 
confirmed by X-ray analyses [ 141. 
Examination of the tertiary structure of the p 
chain indicates that the aspartic acid side-chain could 
probably form a salt bridge with the e amino group 
of lysine 065. In Hb J Nyanza a21 (B2) Ala + Asp, 
which is the homologue on the o-chain of Hb 
Strasbourg [ 151, the charge of the aspartic acid 
residue is not suppressed. Examination of the tertia- 
ry structure of the a-chain showed that the twenty- 
first residue is near the (~59 residue which is a 
glycine; consequently the charge of the aspartic acid 
could not be suppressed. 
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